What do you think of this rise Blackhorse?? |
Time clicking now , don't understand why delaying results, everything computerised now a days unless something wrong |
If delisted then no trades, it will hold until accounts publish and impose fine , ALL ACCOUNTS MUST PUBLISH WITHIN 6 months which will expire for APH end of June |
But if that's happens, shareholders need to be paid out, otherwise Dbays shareholding would be worthless |
Hmm, can there be a danger of share suspension followed by an oppotunistic bid from DBAY? |
This is 17th only 10 days left , 6 months on , don't know why delaying ? No explanation |
Danger is if they fail to publish results then automatically delisted from LSE , that's the rules |
Alliance reiterates that the details provided in the full year trading update on 29 January 2024 remain accurate. |
Something on the way ..she said BOOM! |
I think will come out this week |
10 business days left until suspension. |
Let it go and make a bid of 70-80p :) |
 Trading update for FY results which we are waiting for on as below: Financial summaryThe Group delivered record see-through1 revenues in the Period of £182.7m (FY22: £172.0m), up 6% versus the prior period and up 7% at constant exchange rates ("CER"). Excluding sales from ScarAway and the US rights to Kelo-Cote in Q1 23, both acquired in March 2022 (the "US Acquisition"), like-for-like see-through revenues increased 6% CER. Continued strong consumer demand, particularly in China, drove significant recovery in Kelo-Cote franchise revenues in H2, leading to FY23 revenues of £63.2m, up 29% CER (FY22: £50.0m). Nizoral revenues increased 3% CER to £21.7m (FY22: £21.8m) whilst Amberen revenues declined 6% CER on an underlying basis (excluding the leading discount store account that was lost in 2022) and decreased 25% CER to £11.2m (FY22: £14.9m) on a reported basis. With Other Consumer brands up 5% CER to £40.3m (FY22: £38.4m), total see-through Consumer Healthcare revenues increased 11% CER to £136.4m. Prescription Medicine revenues were stable at £46.3m (FY22: £46.8m), reflecting a strong recovery in H2 as expected, as previously out of stock products became available. Underlying profit for the Period is anticipated to be in-line with market expectations. Cash and debtFree cash flow in the Period rose 34% to £21.1m (FY22: £15.8m) and net debt reduction continued, falling to £92.4m at 31 December 2023 (31 December 2022: £102.0m). Group leverage2 (as at 31 December 2023) is expected to be significantly below that at 30 June 2023 (2.7x), and in-line with previous guidance.OutlookDemand for the Group's brands remains strong. Alliance's clear focus on the core Consumer Healthcare business, in addition to our well-established, scalable platform across EMEA, APAC and the US, is expected to deliver continued strong organic growth over the medium term. In 2024, the Board anticipates our Consumer Healthcare revenues to continue to grow above that of the broader Consumer Healthcare market, with stable Prescription Medicine revenues.In order to achieve our medium-term objectives, in 2024, the Board anticipates increased investment in sales and marketing, both directly and through the Group's distributors. The Company will also continue to deliver innovation in 2024 to further expand the reach of its brands. As a result, the Board anticipates that profits in 2024 will be in-line with 2023. |
It has been valued & got take over offer 100p per share last year, now 33p . Recent trading update (29th January) indicates all up including revenues , gross profits , free cash & debt down. Then recently added 8m from court winning , so it should skyrocket soon |
We'll soon see when Blackrock is finished lending Dbay a hand, and the cold sweating will be over .anyone agree ? ;)) |
Someone is getting cold sweat;)) |
😰😰 |
No pain no gain ;)) |
I know , I think they are doing favour for DBay |
This is painful |
Results will be out next week & patience will be pay off |
Yes don't look great with the constant selling, no wonder certain people are getting desperate and spamming boards more and more each day. |
High risk..maybe Dbay should start reducing again lol :)) |
This is very high risk!! |
Register to chat with like-minded investors on our interactive forums.
Hot Features
Premium
